✦ LIBER ✦

A multiple-center phase II study of biweekly oxaliplatin and tegafur–uracil/leucovorin for chemonaive patients with advanced gastric cancer

✍ Scribed by Jen-Shi Chen; Kun-Ming Rau; Yen-Yang Chen; Jen-Seng Huang; Tsai-Shen Yang; Yung-Chang Lin; Chi-Ting Liau; Kuan-Der Lee; Yu-Cheih Su; Ruey-Ho Kao

Publisher: Springer
Year: 2008
Tongue: English
Weight: 276 KB
Volume: 63
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0797-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of oxaliplatin, UFT, and

Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer

✍ Ester J. M. Siemerink; Annemieke F. J. Drenth; Nanno H. Mulder; John T. M. Plukk 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 245 KB

A multiple-center phase II study of week

A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer

✍ Jen-Shi Chen; Yen-Yang Chen; Jen-Sheng Huang; Kun-Yun Yeh; Ping-Tsung Chen; Wen- 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 181 KB

Combination chemotherapy of biweekly iri

Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients

✍ Koji Okabayashi; Hirotoshi Hasegawa; Yoshiyuki Ishii; Takashi Endo; Hiroki Ochia 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 392 KB

Treatment of patients with advanced gast

Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group

✍ J. Feliu; M. González Barón; C. García-Girón; E. Espinosa; P. García-Alfonso; J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

## Background: Both the biochemical modulation and the continuous administration of 5-fluorouracil (5-fu) have achieved promising results in patients with gastric carcinoma. conversely, several studies on gastric carcinoma have demonstrated that the combination of etoposide (vp-16), leucovorin (lv)

A phase II study of paclitaxel combined

A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer

✍ Chong Kun Im; Hei-Cheul Jeung; Sun Young Rha; Nae Choon Yoo; Sung Hoon Noh; Jae 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB

Phase II study of a modified combination

Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer

✍ Içli, Fikri; Karaoguz, Handan; Akbulut, Hakan; Dinçol, Dilek; Demirkazik, Ahmet; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Background: Based on the promising results of eap (etoposide, doxorubicin, and cisplatin) combination, a phase ii study of modified eap combination was performed in patients with advanced gastric cancer to evaluate the response, toxicity, and survival. ## Method: Fifty-two consecutive patients